Study of Niraparib in Combination with Pembrolizumab in Triple Negative Breast Cancer or Ovarian Cancer - Stand Up To Cancer

Blog

Posted October 11, 2019

Study of Niraparib in Combination with Pembrolizumab in Triple Negative Breast Cancer or Ovarian Cancer

JOIN OUR COMMUNITY

Sign up to receive emails from Stand Up To Cancer.
   Please leave this field empty
Stand Up to Cancer

Thanks for signing up!
You will hear from us soon.